COHEN YUVAL

PrivateCIK: 1626003
Location

NORWOOD, MA

COHEN YUVAL (Chief Executive Officer) sold 16.7% of their position (27.63K shares) of CORBUS PHARMACEUTICALS HOLDINGS, INC. on the open market

Open‑market sale worth $471.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderCOHEN YUVALCIK 1626003
DirectorOfficer· Chief Executive Officer
Since Jan 2019
-27.63K
Net shares
Net seller
$471.2K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
27.63K acquired · 55.27K disposed
Non-Derivative Transactions4

Common Stock, par value $0.0001 per share

Direct
M · Option Exercise

Shares

+18.66K

Price / share

$4.26

Trade value

$79.49K

% of position

13.5%
10/24/2025
138.19K156.85K

Common Stock, par value $0.0001 per share

Direct
S · Sale

Shares

18.66K

Price / share

$17.01

Trade value

$317.41K

% of position

11.9%
10/24/2025
156.85K138.19K

Common Stock, par value $0.0001 per share

Direct
M · Option Exercise

Shares

+8.97K

Price / share

$4.26

Trade value

$38.22K

% of position

6.5%
10/27/2025
138.19K147.16K

Common Stock, par value $0.0001 per share

Direct
S · Sale

Shares

8.97K

Price / share

$17.14

Trade value

$153.80K

% of position

6.1%
10/27/2025
147.16K138.19K
Total

Net shares

+0.00

Net value

-$353.49K

Derivative Transactions2

Stock options (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

18.66K shares

Shares

18.66K

Strike price

4.26

Held after

31.08K

Exercisable

10/24/2025

Stock options (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

8.97K shares

Shares

8.97K

Strike price

4.26

Held after

22.11K

Exercisable

10/27/2025
COHEN YUVAL — Insider Transaction (Form 4) Filed Oct 27, 2025 | Finecho